Correction: Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Amendment: Outcomes of Transplantation in Acute Lymphoblastic Leukemia with Philadelphia Chromosome and Additional Cytogenetic Abnormalities: Research by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

  • By

  • Arnon Nagler

  • Jordi Esteve

  • Jacques-Emmanuel Galimard

  • Depei Wu

  • Erlie Jiang

  • Nathalie Dhedin

  • Anne Sirvent

  • Jan Vydra

  • Jakob Passweg

  • Bruno Lioure

  • Jaime Sanz

  • Jurjen Versluis

  • Yajing Xu

  • Cristina Castilla-Llorente

  • Rodrigo Martino Bufarull

  • Victoria Potter

  • Nour Ben Abdeljelil

  • Eolia Brissot

  • Ali Bazarbachi

  • Bipin Savani

  • Sebastian Giebel

  • Mohamad Mohty

  • Fabio Ciceri

  • August 31, 2026

Share

Original Source(s)

Correction: Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

  • by Arnon Nagler, Jordi Esteve, Jacques-Emmanuel Galimard, Depei Wu, Erlie Jiang, Nathalie Dhedin, Anne Sirvent, Jan Vydra, Jakob Passweg, Bruno Lioure, Jaime Sanz, Jurjen Versluis, Yajing Xu, Cristina Castilla-Llorente, Rodrigo Martino Bufarull, Victoria Potter, Nour Ben Abdeljelil, Eolia Brissot, Ali Bazarbachi, Bipin Savani, Sebastian Giebel, Mohamad Mohty, Fabio Ciceri

  • August 31, 2026

Related Content

This Week’s CGT News: Bristol Myers Ends Cellares Manufacturing Agreement

A first-in-human study reduces stem-cell collection and manufacturing times, Bristol Myers ends its Breyanzi agreement with Cellares, and two approaches strengthen CAR T-cell activity against solid tumors

  • August 31, 2026

  • 5 min
Trastuzumab deruxtecan treatment for HER2-low metastatic scrotal extramammary Paget’s disease with bone marrow involvement: a case report

Cancer Communication in an Era of Fragmented Trust